Sartorius AG reported Q1 net profit of €56.2 million, a 16% increase year‑on‑year.
Group sales rose 1.8% to €899.1 million (7.5% in constant currencies), confirming full‑year guidance of 5‑9% growth.
Bioprocess Solutions division revenue hit €735.1 million (+8.1% cc) with EBITDA €233.4 million, margin 31.8%; Lab Products division sales €164 million (+4.9% cc).
Operating cash flow surged 35.8% to €188.9 million, free cash flow rose 84.6% to €112.9 million, capex €78 million.